Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. musculoskeletal
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • Older

Musculoskeletal Articles & Analysis: Older

91 news found

CELLINK and Ossiform Enter a Strategic Partnership to launch Ossi Ink, a printable bioink based on Ossiform’s P3D Bone material

CELLINK and Ossiform Enter a Strategic Partnership to launch Ossi Ink, a printable bioink based on Ossiform’s P3D Bone material

A recent report by the WHO put the global disease burden of musculoskeletal conditions at 1.71 billion people globally, and the biggest contributing condition to years living with disability. ...

ByCELLINK


Hybrid TTL Loupes: Best of Ergonomics and Direct Vision

Hybrid TTL Loupes: Best of Ergonomics and Direct Vision

The suspended magnification and pantoscopic tilt also help clinicians to work comfortably, precisely, and with reduced musculoskeletal ...

BySurgiTel is a Division of General Scientific Corporation (GSC)


Caira Surgical to Participate in Upcoming Investor Conferences

Caira Surgical to Participate in Upcoming Investor Conferences

Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced today that Jon Greenwald, Chief Executive Officer, and Irina Benimovich, Chief Financial Officer, will conduct investor meetings and host presentations at the upcoming CG 2023 Musculoskeletal Conference and LSI USA '23 partnering event. March 7 – CG 2023 ...

ByCaira Surgical


Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer

Most of the adverse events (AEs), including nausea and musculoskeletal pain were grade 1 and 2. No hematological safety signal was observed and none of the patients in either of the two treatment arms had sinus bradycardia. ...

ByThe Menarini Group


MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

The most common (≥25%) nonhematologic treatment-emergent AEs of any grade were diarrhea (43%), respiratory tract infection (41%), asthenic conditions (38%), musculoskeletal pain (32%), constipation (30%), nausea (29%), dizziness (27%) and abdominal pain (26%). ...

ByMorphoSys AG


A new study confirming correlation between Biomechanical Markers and clinical outcomes in knee OA patients

A new study confirming correlation between Biomechanical Markers and clinical outcomes in knee OA patients

A new study published in BMC Musculoskeletal Disorders confirmed that biomechanical markers are more associated with pain, symptoms and disability compared to imaging findings in knee osteoarthritis patients. ...

ByEmovi


Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

About Active Implants LLC Active Implants LLC develops orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system, allowing patients to maintain or return to an active lifestyle. ...

ByActive Implants LLC


Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego

Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego

About Active Implants Active Implants, LLC develops orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system, allowing patients to maintain or return to an active lifestyle. ...

ByActive Implants LLC


100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface Meniscus Implant

100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface Meniscus Implant

Moorman III, MD) Indianapolis, Indiana – OrthoIndy (Jack Farr, MD) Memphis, Tennessee – OrthoMemphis (Randall Holcomb, MD) New York, New York – Lenox Hill Hospital (Elliott Hershman, MD) Richmond, Virginia – Advanced Orthopaedics (Kenneth Zaslav, MD) Rochester, New York – University of Rochester Medical (Michael Maloney, MD) SUN Study Arlington, Texas ...

ByActive Implants LLC


Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface Meniscus Implant

Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface Meniscus Implant

About Active Implants LLC Active Implants LLC develops orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system, allowing patients to maintain or return to an active lifestyle. ...

ByActive Implants LLC


FDA Approves Taiho’s LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

FDA Approves Taiho’s LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

The most common (≥20%) adverse reactions were nail toxicity, musculoskeletal pain, constipation, diarrhea, fatigue, dry mouth, alopecia, stomatitis, dry skin, arthralgia, dysgeusia, abdominal pain, dry eye, nausea, decreased appetite, urinary tract infection, palmar-plantar erythrodysesthesia syndrome, and vomiting. ...

ByTaiho Oncology, Inc.


Field Orthopaedics announces strategic alliance with Medartis Inc

Field Orthopaedics announces strategic alliance with Medartis Inc

Medartis is a top player in musculoskeletal extremity healthcare and specifically in orthopaedic hand surgery. ...

ByField Orthopaedics


Gesynta Pharma presents results from an exploratory clinical study of its drug candidate GS-248

Gesynta Pharma presents results from an exploratory clinical study of its drug candidate GS-248

The study was conducted at clinical centers in four European countries under the leadership of Professor Ariane Herrick, Division of Musculoskeletal and Dermatological Sciences at the University of Manchester. ...

ByGesynta Pharma AB


Easy integration of VR therapy into everyday practice - example: Neurology practice Düsseldorf

Easy integration of VR therapy into everyday practice - example: Neurology practice Düsseldorf

VR therapy with CUREO shows itself to be a novel, modern way of treating neurological and musculoskeletal diseases. Therefore, many facilities, such as rehabilitation clinics or outpatient practices, initially ask themselves whether VR therapy is also suitable for their own practice, or how the new procedures can be integrated into existing therapy plans. ...

ByCUREosity GmbH


Gesynta Pharma completes patient enrollment in its Phase II study in systemic sclerosis

Gesynta Pharma completes patient enrollment in its Phase II study in systemic sclerosis

Professor Ariane Herrick, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, is Coordinating Investigator for the study, which is conducted at clinical sites in four European countries. ...

ByGesynta Pharma AB


SANUWAVE Health and JV Partner Diversa S.A. Announce Distribution Agreement with Grupo Suprimed

SANUWAVE Health and JV Partner Diversa S.A. Announce Distribution Agreement with Grupo Suprimed

About SANUWAVE Health SANUWAVE Health (OTCQB: SNWV) is focused on the research, development, and commercialization of its patented, Energy First non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and ...

BySanuwave and Sanuwave Health, Inc.


Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

Second, physicians using the R-One robotic system do not need to wear heavy lead protective gear; preventing musculoskeletal conditions caused by the long-term use of such equipment. ...

ByRobocath


Using fungi to slow down cellular ageing

Using fungi to slow down cellular ageing

Our work on advanced arthritis has been accepted by the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases and two other papers have recently been published in Plos One and the European Journal of Dermatology. ...

ByKiOmed Pharma


SANUWAVE Health Announces Patent Activity from March 2021 to March 2022

SANUWAVE Health Announces Patent Activity from March 2021 to March 2022

” About SANUWAVE SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates ...

BySanuwave and Sanuwave Health, Inc.


SANUWAVE Announces New Board Leadership

SANUWAVE Announces New Board Leadership

” About SANUWAVE SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates ...

BySanuwave and Sanuwave Health, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT